Biosensors International
Drug-eluting stent, Biolimus A9, Restenosis
978-613-8-09531-6
6138095316
52
2012-07-16
29,00 €
eng
https://images.our-assets.com/cover/230x230/9786138095316.jpg
https://images.our-assets.com/fullcover/230x230/9786138095316.jpg
https://images.our-assets.com/cover/2000x/9786138095316.jpg
https://images.our-assets.com/fullcover/2000x/9786138095316.jpg
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Biosensors International Group (SGX: B20) is a company that specializes in developing, manufacturing and marketing innovative medical devices for use in interventional cardiology and critical care procedures. The company was established in 1990 and was listed on the Singapore Stock Exchange (SGX) in May 2005. The global headquarters of the company are based in Morges, Switzerland, with the main R&D and manufacturing base located in Singapore. With the increasing use of the BioMatrix™ family of drug-eluting stents, the company is rapidly emerging as a leader in the global coronary stent market. The forthcoming launch of the Axxess™ self-expanding bifurcation drug-eluting stent and the development of the BioFreedom™ drug-coated stent will further reinforce this market position.
https://morebooks.de/books/de/published_by/fer-publishing/189853/products
Neuzeit bis 1918
https://morebooks.de/store/de/book/biosensors-international/isbn/978-613-8-09531-6